The mortality rate for malignant neoplasms of the colon, rectum, and anus among US females is forecasted to decline from 14.1 deaths per hundred thousand women in 2024 to 13.6 by 2028. This reflects a year-on-year decline of approximately 0.7%, indicating a steady reduction trend. Compared to 2023, the rate stood at 14.2, which shows a slight decreasing trajectory over the years. Over a five-year span, the Compound Annual Growth Rate (CAGR) is approximately -0.9%, highlighting continued progress in health interventions and early detection strategies.
Future trends to watch include advances in screening technologies, increased awareness about prevention and lifestyle changes, and enhanced treatment protocols. These could further accelerate the reduction in mortality rates.
